Apyx Medical Corporation (APYX)

US — Healthcare Sector
Peers: CVRX  NPCE  ANIK  AXGN  CRNX  IDYA  HROW  EVLO  IRMD 

Automate Your Wheel Strategy on APYX

With Tiblio's Option Bot, you can configure your own wheel strategy including APYX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol APYX
  • Rev/Share 1.142
  • Book/Share 0.1831
  • PB 11.6802
  • Debt/Equity 0.6498
  • CurrentRatio 4.7241
  • ROIC -0.26

 

  • MktCap 78664560.0
  • FreeCF/Share -0.2463
  • PFCF -7.8429
  • PE -4.9085
  • Debt/Assets 0.081
  • DivYield 0
  • ROE -1.6049

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation APYX BTIG Research -- Neutral -- -- Oct. 17, 2024

News

Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript
APYX
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Neutral

Apyx Medical Corporation (NASDAQ:APYX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Charles D. Goodwin - President, CEO & Director Matthew C.

Read More
image for news Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript
Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript
APYX
Published: March 13, 2025 by: Seeking Alpha
Sentiment: Neutral

Apyx Medical Corporation (NASDAQ:APYX ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Jeremy Feffer - MD, LifeSci Advisors Charlie Goodwin - CEO Matt Hill - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Sam Eiber - BTIG Operator Greetings. Welcome to the Apyx Medical Fourth Quarter and Full Year 2024 Conference Call.

Read More
image for news Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
APYX
Published: March 13, 2025 by: Zacks Investment Research
Sentiment: Negative

Apyx Medical (APYX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.19 per share a year ago.

Read More
image for news Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates

About Apyx Medical Corporation (APYX)

  • IPO Date 2019-01-02
  • Website https://www.apyxmedical.com
  • Industry Medical - Devices
  • CEO Charles D. Goodwin II
  • Employees 220
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.